Somatic mutations in genes RUNX1, TP53, ASXL1, and WT1, which also occur in other myeloid malignancies, have been found with a high prevalence in adult patients with CML-BP. This evidence concerns the gene RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive.